The Sprouty/Spred family as tumor suppressors: Coming of age
Tetsuro Kawazoe1,2, Koji Taniguchi1
1Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan.
Abstract:
The Ras/Raf/ERK pathway is one of the most frequently dysregulated signaling pathways in various cancers. In some such cancers, Ras and Raf are hotspots for mutations, which cause continuous activation of this pathway. However, in some other cancers, it is known that negative regulators of the Ras/Raf/ERK pathway are responsible for uncontrolled activation. The Sprouty/Spred family is broadly recognized as important negative regulators of the Ras/Raf/ERK pathway, and its expression is downregulated in many malignancies, leading to hyperactivation of the Ras/Raf/ERK pathway. After the discovery of this family, intensive research investigated the mechanism by which it suppresses the Ras/Raf/ERK pathway and its roles in developmental and pathophysiological processes. In this review, we discuss the complicated roles of the Sprouty/Spred family in tumor initiation, promotion, and progression and its future therapeutic potential.
Insights
The Sprouty/Spred family negatively regulates the Ras/Raf/ERK pathway. Its downregulation in cancer leads to pathway hyperactivation, presenting therapeutic opportunities.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- The Ras/Raf/ERK pathway is crucial in cell signaling and frequently dysregulated in cancers.
- Mutations in Ras and Raf can cause pathway hyperactivation, but negative regulators also play a role.
- The Sprouty/Spred family are key negative regulators of this pathway, often downregulated in malignancies.
Purpose of the Study:
- To review the complex roles of the Sprouty/Spred family in cancer.
- To explore the mechanisms by which Sprouty/Spred proteins suppress the Ras/Raf/ERK pathway.
- To discuss the therapeutic potential of targeting the Sprouty/Spred family in cancer treatment.
Main Methods:
- Literature review of studies on the Sprouty/Spred family and Ras/Raf/ERK pathway.
- Analysis of research on the expression and function of Sprouty/Spred proteins in various cancers.
- Synthesis of findings regarding the involvement of Sprouty/Spred in tumor initiation, promotion, and progression.
Main Results:
- Sprouty/Spred family expression is frequently downregulated in cancers, leading to Ras/Raf/ERK pathway hyperactivation.
- These proteins act through various mechanisms to inhibit signal transduction downstream of Ras.
- Dysregulation of Sprouty/Spred contributes to tumor initiation, promotion, and progression.
Conclusions:
- The Sprouty/Spred family plays a critical, albeit complex, role in cancer development.
- Understanding these roles is essential for developing targeted cancer therapies.
- The Sprouty/Spred family represents a promising target for future cancer treatments.
More Related Videos
Related Concept Videos
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Protein Families
Protein Families
Gene Families
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
Gene Families
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...


